Communiqués Medicalgorithmics S.A.

Actions

MDG

PLMDCLG00015

Equipement et technologie médicale avancés

Cours en clôture Warsaw S.E. 05/10/2026			Varia. 5j.	Varia. 1 janv.
25,20 ^PLN	0,00%		-0,40%	-25,00%

29/09	Medicalgorithmics S.A. publie ses résultats pour le deuxième trimestre et les six mois clos le 30 juin 2026	CI
01/06	Medicalgorithmics signe un accord avec Accyourate Group pour des services basés sur la plateforme DeepRhythm et les algorithmes DeepRhythmAI	RE

Communiqués

22/06	Medicalgorithmics S A : Advances AI Research Pipeline Targeting Automated Diagnostics and Population-Scale Cardiac Prevention	PU
10/06	Medicalgorithmics S A : Biofund is proceeding with its plans to convert the loan granted to Medicalgorithmics. The General Meeting will make a key decision	PU
02/06	Medicalgorithmics S A : is entering a business talks with a global MedTech company listed on the NYSE with a multi-billion-dollar business	PU
01/06	Medicalgorithmics S A : a technology partnership with Accyourate, an Italian wearable healthcare company	PU
29/05	Medicalgorithmics S A : Summarizes the Q1 2025 51% revenue growth, positive EBITDA, and positive operating cash flow	PU
29/04	Medicalgorithmics S A : summarizes 2025. Revenue of PLN 31 million (+29%) and an operating cash break-even in the fourth quarter of the year.	PU
28/04	Medicalgorithmics S A : is supporting its Canadian partner in its development. An additional order worth USD 0.5 million.	PU
27/04	Medicalgorithmics S A : will convert Biofund’s loan into shares at a price of PLN 33. The Company’s General Meeting of Shareholders will take a key decision.	PU
09/04	Medicalgorithmics S A : ends the first quarter of this year with a 51% increase in revenue and positive EBITDA	PU
30/03	Medicalgorithmics S A : will support new South Korean partner in the U.S. market expansion	PU
27/01	Medicalgorithmics S A : Nationale-Nederlanden PTE – the largest institutional investor in the CEE region joins Medicalgorithmics’ shareholding structure	PU
20/01	Medicalgorithmics S A : strengthens Shareholder structure. Investors acquire shares worth nearly PLN 70 million	PU
19/01	Medicalgorithmics signs first South American distribution deal	AQ
19/01	Medicalgorithmics S A : enters South America. The company has signed an agreement with Sharp Tech, a leading distributor in Peru.	PU
07/01	Medicalgorithmics S A : ends the year with record 74% revenue growth and positive EBITDA in Q4 2025.	PU
05/01	Medicalgorithmics S A : Strong beginning of the year for Medicalgorithmics Polish medtech company signs agreement with another American IDTF	PU
18/12	Medicalgorithmics S A : has signed an agreement with PARP. The company will receive PLN 9.4 million for the development of a project based on VCAST technology	PU
02/12	Medicalgorithmics S A : signs a new contract worth at least USD 5.9 million with its second largest customer	PU
01/12	Medicalgorithmics S A : expands cooperation with its largest client – one of the largest U.S. IDTFs, increasing remuneration under the cooperation by over 50% in December 2025, to USD 450–500 thousand	PU
27/11	Medicalgorithmics S A : integrates two further clients. Samsung spin-off among them	PU
10/11	New, groundbreaking results from the DRAI MARTINI study: the risk of failing to detect a clinically meaningful rhythm disturbances reduced 75 to 114 times by DeepRhythmAI analysis.	PU
06/11	Medicalgorithmics on a dynamic growth path in Q3 2023. Revenue up 38% y/y, driven by sales in the US: +76% y/y.	PU
04/11	Medicalgorithmics S A : and Lund University Launch Landmark AI Initiative to Build the World’s Largest Cardiac Function Dataset and Establish a New Global Standard in Non-Invasive Heart Diagnostics	PU
03/11	Medicalgorithmics S A : signs a contract worth at least PLN 439,2k per year for the provision of ECG diagnostic services with the largest private service provider (IDTF) in the United Kingdom.	PU
20/10/25	Medicalgorithmics S A : enters the key Middle Eastern market – Saudi Arabia – with its groundbreaking VCAST solution	PU